Dómine, M. http://orcid.org/0000-0002-1128-434X
Moran, T.
Isla, D.
Martí, J. L.
Sullivan, I. http://orcid.org/0000-0002-0434-3436
Provencio, M.
Olmedo, M. E.
Ponce, S.
Blasco, A.
Cobo, M.
Article History
Received: 7 January 2020
Accepted: 7 January 2020
First Online: 10 February 2020
Compliance with ethical standards
:
: MD reports lecture and advisory board from AstraZeneca, BMS and Boehringer Ingelheim, outside the submitted work. TM has nothing to disclose. DI reports personal financial interests: Consulation Honoraria from AbbVie, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, F. Hoffmann-La Roche, MSD, Pierre Fabre, Pfizer, and Takeda; Speaker Honoraria from AstraZeneca, Bayer, BMS, Boehringer Ingelheim, F. Hoffmann-La Roche, MSD, Pierre Fabre and Pfizer. Institutional financial interests: Clinical Trials from AbbVie, AstraZeneca, Boehringer Ingelheim, BMS, F. Hoffmann-La Roche, Janssen, Merck, MSD, Novartis; Research Grant from BMS, F. Hoffmann-La Roche. Non-financial interests: Leadership Role from SEOM (Spanish Society of Medical Oncology): Scientific Assistant. Other: Executive Board Member of the Commission for the Approval of New Drugs, Regional Health Care Department, Spain. JLM reports honoraria from Roche, outside the submitted work. IS reports personal fees from Roche, MSD, BMS, AstraZeneca, Boehringer Ingelheim, Pfizer and Novartis, and non-financial support from Novartis, outside the submitted work. MP reports honoraria for speaking and advisory board from BMS, AstraZeneca, Takeda, Roche and Amgen, outside the submitted work. MEO has nothing to disclose. SP has nothing to disclose. AB has nothing to disclose. MC reports lecture and advisory board from AstraZeneca, BMS, Boehringer Ingelheim, outside the submitted work.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable.